Impact of MOUD Policy Changes During the Pandemic on Opioid and Alcohol Use Disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses data from the Veterans Health Administration to examine how pandemic-era MOUD policy changes influenced treatment receipt, retention, and associated outcomes for people with opioid use disorder, compared with a similar group with alcohol use disorder. It employs interrupted time-series or difference-in-difference designs to assess pre- and post-policy periods and to compare across diagnostic groups. The project includes qualitative interviews with veterans, MOUD providers, and VA leadership to contextualize quantitative findings and explore implementation factors. Lead sponsorship is from Boston University with collaboration from PCORI, and the VA Boston Healthcare System serves as the study site.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Substance use disorder (alcohol and/or opioid) documented in the Veteran's Health Administration Corporate Data Warehouse (CDW)

Exclusion Criteria:

* None

Where it's running

• VA Medical Center
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Nicholas Livingston, PhD — BUCA School of Medicine, Psychiatry and VA Medical Center
• Study coordinator: Nicholas Livingston, PhD
• Email: livingn@bu.edu
• Phone: 857-364-6612

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Engagement of community health workers to support recovery from substance use disorders

  This study is testing whether support from community health workers can help people with substance use disorders engage better in treatment and improve their recovery experience after visiting the emergency department.

  Recruiting University of California, Los Angeles · Providence, Rhode Island · NCT06320015

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

• Brief alcohol-focused program tailored for people taking buprenorphine

  This project will try a short, opioid-informed alcohol counseling program for adults on prescribed buprenorphine who drink alcohol to see if it reduces drinking and helps them stay in treatment.

  Recruiting University of Notre Dame · Notre Dame, Indiana · NCT07342504

• Transcutaneous auricular neurostimulation (tAN) for reducing alcohol withdrawal in people with alcohol use disorder

  This trial will try a five-day ear‑stimulation device (tAN) versus a sham device to reduce alcohol withdrawal symptoms in adults with moderate-to-severe alcohol use disorder.

  Recruiting Spark Biomedical, Inc. · Houston, Texas · NCT07281261

• TMS to help recovery in people with opioid and alcohol use disorders

  This study tests whether short daily TMS sessions can help people with opioid and alcohol use disorders improve recovery outcomes when added to their regular treatment.

  Recruiting Washington State University · Portland, Oregon · NCT07171359

• Using brain stimulation to reduce cravings and improve control in people with substance use disorders

  This study is testing if a type of brain stimulation can help people with alcohol use disorder feel less cravings and have better control during their detox treatment.

  Recruiting Central Institute of Mental Health, Mannheim · Mannheim and 1 other locations · NCT06959342

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.